| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 52.31B | 57.53B | 51.71B | 42.67B | 37.26B | 35.19B |
| Gross Profit | 8.21B | 9.05B | 8.05B | 7.08B | 7.00B | 5.63B |
| EBITDA | 3.03B | 3.00B | 2.86B | 2.34B | 3.03B | 2.26B |
| Net Income | 1.53B | 1.43B | 1.39B | 1.11B | 1.58B | 1.22B |
Balance Sheet | ||||||
| Total Assets | 55.49B | 57.31B | 54.51B | 48.45B | 43.44B | 31.98B |
| Cash, Cash Equivalents and Short-Term Investments | 8.04B | 9.97B | 6.90B | 8.90B | 6.82B | 7.91B |
| Total Debt | 39.65B | 35.58B | 38.38B | 32.40B | 28.81B | 20.06B |
| Total Liabilities | 43.96B | 41.95B | 43.23B | 37.99B | 33.87B | 23.76B |
| Stockholders Equity | 11.43B | 15.14B | 11.18B | 10.36B | 9.48B | 8.15B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 3.80B | -7.36B | -742.99M | -9.38B | 52.79M |
| Operating Cash Flow | 0.00 | 3.80B | -7.31B | -691.23M | -9.31B | 127.48M |
| Investing Cash Flow | 0.00 | -51.32M | -102.32M | -359.91M | -285.83M | 28.19M |
| Financing Cash Flow | 0.00 | -662.36M | 5.39B | 3.13B | 8.50B | 2.56B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
76 Outperform | ¥21.90B | 11.93 | ― | 4.36% | -0.08% | -1.83% | |
65 Neutral | $2.17B | 12.19 | 3.79% | 4.94% | 3.15% | 1.96% | |
64 Neutral | ¥23.39B | 36.89 | ― | ― | -2.59% | 61.28% | |
56 Neutral | ¥28.93B | 5.93 | ― | 6.11% | -9.84% | 10.13% | |
52 Neutral | ¥39.73B | 21.02 | ― | 0.45% | 23.11% | 8.31% | |
50 Neutral | ¥17.36B | 12.34 | ― | 2.89% | 11.26% | 0.32% | |
49 Neutral | ¥17.71B | 4.91 | ― | 3.54% | 12.77% | 32.07% |